Transient Willis-Ekbom's disease (restless legs syndrome) during pregnancy may be caused by estradiol-mediated dopamine overmodulation

Medical Hypotheses

Volumn 80, Issue 2, 2013, Pages 205-208

  Pereira, José Carlos ^a   Rocha e Silva, Ingrid Ramos ^b   Pradella Hallinan, Márcia ^c  

^a FACULDADE DE MEDICINA DE JUNDIAÍ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Universidade Federal Paulista   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ESTRADIOL; FOLIC ACID; THYROID HORMONE; THYROTROPIN; THYROXINE;

ARTICLE; HUMAN; HYPERTHYROIDISM; PATHOPHYSIOLOGY; PREGNANCY; RESTLESS LEGS SYNDROME; THYROID GLAND; WILLIS EKBOM DISEASE;

DOPAMINE; ESTRADIOL; FEMALE; HUMANS; IRON; MODELS, BIOLOGICAL; PREGNANCY; RESTLESS LEGS SYNDROME; THYROID HORMONES; THYROTROPIN;

EID: 84872357722     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.11.030     Document Type: Article

References (36)

1. Ekbom K.-A. Restless legs: a clinical study. Acta Med Scand 1945, 158:1-122.
2. Ekbom K., Ulfberg J. Restless legs syndrome. J Intern Med 2009, 266(5):419-431.
3. Allen R. Restless legs syndrome (Willis-Ekboma disease). Clinical sleep disorders 2012, 203-218. Lippincott Williams & Wilkins, Philadelphia. 2nd ed. P.R. Carney, J.D. Geyer, R.B. Berry (Eds.).
4. Alves D.A., Carvalho Morais J.F., Prado G.F. Restless legs syndrome during pregnancy in Brazilian women. Sleep Med 2010, 11(10):1049-1054.
5. Manconi M., Govoni V., De Vito A., Economou N.T., Cesnik E., Casetta I., et al. Restless legs syndrome and pregnancy. Neurology 2004, 63(6):1065-1069.
6. Pereira J.C., Pradella-Hallinan M., Lins Pessoa J.H. Imbalance between thyroid hormones and the dopaminergic system might be central to restless legs syndrome pathophysiology: a hypothesis. Clinics 2010, 65(5):547-554.
7. Delitala G. Dopamine and TSH secretion in man. Lancet 1977, 310:760-761.
8. Scanlon M.F., Weetman A.P., Lewis M., Pourmand M., Rodrigues A., Weightman D.R. Dopaminergic modulation of circadian thyrotropin rhythm and thyroid hormone levels in euthyroid subjects. J Clin Endocrinol Metabol 1980, 51:1251-1256.
9. Guyton A.C. Textbook of medical physiology 1981, WB Saunders Company. 7th ed.
10. Nunez J., Celi F.S., Ng L., Forrest D. Multigenic control of thyroid functions in the nervous system. Mol Cell Endocrinol 2008, 287(1-2):1-12.
11. Pereira J.C., Alves R.C. The "forbidden zone for sleep" might be caused by the evening thyrotropin surge and its biological purpose is to enhance survival: a hypothesis. Sleep Sci 2011, 4(2):1-5.
12. Preissner S., Kroll K., Dunkel M., Senger C., Goldsobel G., Kuzman D., et al. SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 2010 Jan, 38(Database issue):D237-D243.
13. Pereira Jr JC, Alves RC, Pradella-Hallinan M. Saint John's Wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate Willis-Ekbom's disease symptoms. Presented in the 21st congress of the European sleep research society, Paris, France; Sep 4-8; 2012 [requests to jcpereirajr@uol.com.br].
14. Hening W.A., Allen R.P., Walters A.S., Chokroverty S. Motor functions and dysfunctions of sleep. Sleep disorders medicine 2009, 397-435. Saunders, Elsevier, Philadelphia. S. Chokroverty (Ed.).
15. Trenkwalder C., Hening W.A., Montagna P., Oertel W.H., Allen R.P., Walters A.S., et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008, 23(16):2267-2302.
16. Tan E.K., Ho S.C., Eng P., Loh L., Koh L., Lum S., et al. Restless legs symptoms in thyroid disorders. Parkinsonism Relat Disord 2004, 10:149-151.
17. Schuppert F., Diegelmann B., Geest T., Wagner T.O., von-zur Muhlen A. Loss of variability in Graves' disease stimulatory TSH-receptors antibodies bind to the TSH-receptor in a continued non pulsatile and non-chaotic fashion. Chronobiologia 1994, 21:21-32.
18. Ekbom K.A. Restless legs in amputees. Acta Med Scand 1961, 169(4):419.
19. Pereira J.C., Alves R.C. The labelled-lines principle of the somatosensory physiology might explain the phantom limb phenomenon. Med Hypotheses 2011, 77(5):853-856.
20. Pereira J.C., Silva Neto J.L.P., Pradella-Hallinan Restless legs syndrome in subjects with knee prosthesis: evidence that symptoms are generated in the periphery. Clinics 2011, 66(11):1955-1959.
21. Taylor R.N., Lebovic D.I. The endocrinology of pregnancy. Greenspan's basic & clinical endocrinology 2007, 641-659. McGraw Hill. 8th ed. D.G. Gardner, D. Shoback (Eds.).
22. Glinoer D. The regulation of thyroid function during normal pregnancy: importance of the iodine status. Best Pract Res Clin Endocrinol Metab 2004, (18):133-152.
23. Dzaja A., Wehrle R., lancel M., Pollmacher T. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep 2009, 32:169-174.
24. Ben-Jonathan N., Hnasco R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001, 22(6):724-763.
25. Shaw-Bruha C.M., Happe H.K., Murrin L.C., Rodriguez-Sierra J.F., Shull J.D. 17beta-Estradiol inhibits the production of dopamine by the tuberoinfundibular dopaminergic neurons of the male rat. Brain Res Bull 1996, 40(1):33-36.
26. Cramer O.M., Parker R.C., Porter J.C. Estrogen inhibition of dopamine release into hypophysial portal blood. Endocrinology 1979, 104(2):419-422.
27. MohanKumar B.S., Kasturi B.S., Shin A.C., Balasubramanian P., Gilbreath E.T., Subramanian M., et al. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia. Am J Physiol Regul Integr Comp Physiol 2001, 300(3):693-699.
28. Peters L.L., Hoefer M.T., Ben-Jonathan The posterior pituitary: regulation of anterior pituitary prolactin secretion. Science 1981, 213(4508):659-661.
29. Shupnik M.A., Greenspan S.L., Ridgway E.C. Transcriptional regulation of thyrotropin subunit by thyrotropin-releasing hormone and dopamine in pituitary cell culture. J Biol Chem 1986, 261(12):675-679.
30. Wójcikowski J., Daniel W.A. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat. Expert Opin Drug Metab Toxicol 2009, 5(6):631-645.
31. Wójcikowski J., Golembiowska K., Daniel W.A. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications. Biochem Pharmacol 2008, 12:675-679.
32. Lee K.A., Zafke M.E., Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Women Health Gend Based Med 2001, 10(4):335-341.
33. Huebers H.A. Non hematological manifestations of iron deficiency. Iron metabolism in infants 1990, 63-72. CRC Press. Bo Lonnerdal (Ed.).
34. Dallman P.R., Goodman The effects of iron deficiency on the hepatocyte. A biochemical and ultrastructural study. JCB 1971, 48:79-90.
35. Cupp M.J., Tracy T.S. Cytochrome P450: new nomenclature and clinical implications. Am Fam Phys 1998, 57:117-126.
36. Coppen A., Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000, 60(2):121-130.